A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...